NKILA interacting with NF‐κB: IκB complex, thus inhibiting the phosphorylation of IκB in breast cancer cells 15; herein, we validated whether NKILA could combine with NF‐κB: IκB complex in laryngeal cancer cell lines. Here, NFKB1 is linked to breast carcinoma.